Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
about
Metabolomics of Ramadan fasting: an opportunity for the controlled study of physiological responses to food intakeOn the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studiesTianma modulates blood vessel tonicityUrine Metabolite Profiles Predictive of Human Kidney Allograft Status.Key elements of metabolomics in the study of biomarkers of diabetes.Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.Anti-Atherosclerotic Action of Agmatine in ApoE-Knockout Mice.Plasma lipidomics reveals potential lipid markers of major depressive disorder.Dietary fat differentially influences the lipids storage on the adipose tissue in metabolic syndrome patients.Metabolomics as a tool for personalizing medicine: 2012 update.
P2860
Q33776724-6ADA63F8-FD51-4E44-AF32-E04E6B8341FEQ34294536-3EE9207D-24B1-4D5E-BBD5-A280F27E2A1CQ36081879-82B6F00F-D2B6-4725-87CF-F639972C3924Q36514964-00926971-BE52-4852-AAB8-64A6383528FAQ38974645-43F1A9B5-AC32-4AD9-A7D1-9FC4A5C2FEF4Q39078185-E6AA5293-7BD5-49FB-8240-DC93CF0544C6Q41573731-D063FA53-9129-4D2F-8C79-60CA8F2B69A4Q46511372-A0A2F1F2-C662-407B-B009-36600C74DFFBQ47842282-3D9A0899-ABF8-48E6-B3CA-02D7BE9DA862Q54257582-F02CF46C-BBA3-4708-8FEC-43AEBFB0ADEE
P2860
Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Identification of a potential ...... s in preclinical drug testing.
@en
Identification of a potential ...... s in preclinical drug testing.
@nl
type
label
Identification of a potential ...... s in preclinical drug testing.
@en
Identification of a potential ...... s in preclinical drug testing.
@nl
prefLabel
Identification of a potential ...... s in preclinical drug testing.
@en
Identification of a potential ...... s in preclinical drug testing.
@nl
P2093
P50
P356
P1476
Identification of a potential ...... s in preclinical drug testing.
@en
P2093
Gerd Luippold
Jerzy Adamski
Robert Augustin
P304
P356
10.1177/1087057111402200
P577
2011-05-04T00:00:00Z